MA33003B1 - Solutions pediatriques comprenant un betabloquant - Google Patents

Solutions pediatriques comprenant un betabloquant

Info

Publication number
MA33003B1
MA33003B1 MA34064A MA34064A MA33003B1 MA 33003 B1 MA33003 B1 MA 33003B1 MA 34064 A MA34064 A MA 34064A MA 34064 A MA34064 A MA 34064A MA 33003 B1 MA33003 B1 MA 33003B1
Authority
MA
Morocco
Prior art keywords
blockers
treatment
solution
containing beta
children containing
Prior art date
Application number
MA34064A
Other languages
Arabic (ar)
English (en)
Inventor
Christine Chaumont
Jean-François Cordoliani
Elie Leverd
Valérie Muguet
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40940328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33003(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MA33003B1 publication Critical patent/MA33003B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention porte sur des solutions non alcoolisées aqueuses comprenant un bétabloquant, un édulcorant de type non sucre et étant sensiblement exemptes d'un agent conservateur aromatique. Les solutions de la présente invention sont particulièrement adaptées pour une utilisation pédiatrique.
MA34064A 2009-04-21 2010-04-12 Solutions pediatriques comprenant un betabloquant MA33003B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09290298A EP2246044A1 (fr) 2009-04-21 2009-04-21 Solutions pédiatriques de bêta-bloquants
PCT/IB2010/051573 WO2010122442A1 (fr) 2009-04-21 2010-04-12 Solutions pédiatriques comprenant un bétabloquant

Publications (1)

Publication Number Publication Date
MA33003B1 true MA33003B1 (fr) 2012-01-02

Family

ID=40940328

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34064A MA33003B1 (fr) 2009-04-21 2010-04-12 Solutions pediatriques comprenant un betabloquant

Country Status (32)

Country Link
US (2) US20120035270A1 (fr)
EP (4) EP2246044A1 (fr)
JP (1) JP5695029B2 (fr)
KR (1) KR101713866B1 (fr)
CN (1) CN102405041A (fr)
AR (2) AR076338A1 (fr)
AU (1) AU2010240551B2 (fr)
BR (1) BRPI1015447B1 (fr)
CA (1) CA2755175C (fr)
CL (1) CL2011002634A1 (fr)
CO (1) CO6410278A2 (fr)
CY (2) CY1119390T1 (fr)
DK (2) DK2497461T4 (fr)
ES (2) ES2685178T5 (fr)
GE (1) GEP20146087B (fr)
HR (2) HRP20170610T4 (fr)
HU (2) HUE039937T2 (fr)
IL (1) IL214674A (fr)
LT (2) LT2421504T (fr)
MA (1) MA33003B1 (fr)
MX (1) MX337463B (fr)
NZ (1) NZ594592A (fr)
PL (2) PL2497461T5 (fr)
PT (2) PT2497461T (fr)
RS (2) RS57668B2 (fr)
RU (1) RU2011139233A (fr)
SG (1) SG172960A1 (fr)
SI (2) SI2497461T2 (fr)
TN (1) TN2011000350A1 (fr)
TW (1) TWI429459B (fr)
UA (1) UA107570C2 (fr)
WO (1) WO2010122442A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246044A1 (fr) 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Solutions pédiatriques de bêta-bloquants
CN103501775A (zh) * 2011-03-04 2014-01-08 格吕伦塔尔有限公司 他喷他多的胃肠外给药
MX388963B (es) 2011-03-04 2025-03-20 Gruenenthal Gmbh Formulacion farmaceutica acuosa de tapentadol para administracion oral
JP2019142972A (ja) * 2011-03-04 2019-08-29 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
US9724297B2 (en) 2014-04-01 2017-08-08 Arbor Pharmaceuticals, Inc. Sotalol compositions and uses of the same
PE20171651A1 (es) 2015-03-27 2017-11-13 Gruenenthal Chemie Formulacion estable para administracion parenteral de tapentadol
EP3515412B1 (fr) 2016-09-23 2025-04-23 Grünenthal GmbH Formulation stable pour l'administration parentérale de tapentadol
CN108261411B (zh) * 2016-12-30 2021-04-30 武汉科福新药有限责任公司 用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法
CN107320467A (zh) * 2017-07-21 2017-11-07 江苏云阳集团药业有限公司 一种盐酸普萘洛尔药用组合物及其制备方法
CN108299279B (zh) * 2018-02-09 2021-03-23 北京梅尔森医药技术开发有限公司 取代芳基胺醇化合物及其制备方法和用途
US11547123B2 (en) * 2019-08-16 2023-01-10 The Folger Coffee Company Methods for reducing negative flavor attributes in coffee and compositions therefrom
US10610502B1 (en) * 2019-08-30 2020-04-07 Metacel Pharmaceuticals, LLC Oral baclofen solutions
JPWO2022071481A1 (fr) 2020-09-30 2022-04-07
CN116407495A (zh) * 2023-03-09 2023-07-11 北京梅尔森医药技术开发有限公司 一种阿替洛尔口服溶液及其制备方法和应用
GB2628566A (en) 2023-03-29 2024-10-02 Novumgen Ltd An orally rapidly disintegrating tablet of propranolol and its process of preparation
WO2025068937A1 (fr) 2023-09-30 2025-04-03 Liqmeds Worldwide Limited Formulation liquide orale de métoprolol
CN118021718B (zh) * 2024-04-12 2024-07-02 成都瑞尔医药科技有限公司 一种盐酸普罗帕酮注射液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600708A (en) 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
HU209251B (en) 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
EP0732064B1 (fr) 1995-03-15 2001-06-06 Kao Corporation Utilisation d'un agent pour réduire l'amertume
JPH1025253A (ja) * 1996-07-12 1998-01-27 Kao Corp 苦味低減化剤及び苦味低減化法
JPH11349492A (ja) * 1998-06-03 1999-12-21 Yamanouchi Pharmaceut Co Ltd 苦味を低減した経口用医薬組成物および苦味低減化方法
JP2001342151A (ja) * 2000-03-31 2001-12-11 Eisai Co Ltd 甘味を有する薬剤組成物
DE60213592T2 (de) * 2001-05-25 2007-08-09 Warner-Lambert Co. Llc Flüssige pharmazeutische zusammensetzung
EP1543831A1 (fr) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Composition de pregabaline
WO2006093493A1 (fr) * 2005-02-25 2006-09-08 Biomarin Pharmaceutical Inc. Composition pharmaceutique liquide aqueuse stable a temperature ambiante
EP1888030A1 (fr) * 2005-05-25 2008-02-20 Janssen Pharmaceutica N.V. Formulation pédiatrique de topiramate
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
EP2050441A1 (fr) 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Utilisation de bêtabloquants pour la fabrication d'un médicament pour le traitement d'hémangiomes
EP2268282B1 (fr) * 2008-04-25 2014-10-29 Apotex Technologies Inc. Formulation liquide de défériprone de goût agréable
EP2246044A1 (fr) 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Solutions pédiatriques de bêta-bloquants

Also Published As

Publication number Publication date
EP3384899A1 (fr) 2018-10-10
ES2623936T3 (es) 2017-07-12
WO2010122442A1 (fr) 2010-10-28
PT2421504T (pt) 2017-06-16
DK2497461T3 (en) 2018-09-03
IL214674A (en) 2017-01-31
TN2011000350A1 (en) 2013-03-27
CY1120667T1 (el) 2019-12-11
MX337463B (es) 2016-03-07
HRP20181408T1 (hr) 2018-11-02
RU2011139233A (ru) 2013-05-27
PL2497461T5 (pl) 2022-06-27
EP2497461B2 (fr) 2021-12-15
IL214674A0 (en) 2011-09-27
RS57668B1 (sr) 2018-11-30
CA2755175C (fr) 2018-01-02
AR117621A2 (es) 2021-08-18
BRPI1015447A8 (pt) 2017-10-03
UA107570C2 (xx) 2015-01-26
MX2011010766A (es) 2011-10-21
NZ594592A (en) 2013-11-29
LT2421504T (lt) 2017-06-12
AR076338A1 (es) 2011-06-01
SI2497461T2 (sl) 2022-04-29
EP2421504A1 (fr) 2012-02-29
AU2010240551B2 (en) 2015-07-16
DK2421504T3 (en) 2017-05-01
JP5695029B2 (ja) 2015-04-01
US20150087719A1 (en) 2015-03-26
BRPI1015447A2 (pt) 2016-04-19
CY1119390T1 (el) 2018-02-14
HRP20170610T1 (hr) 2017-07-28
EP2246044A1 (fr) 2010-11-03
TWI429459B (zh) 2014-03-11
PT2497461T (pt) 2018-10-23
CN102405041A (zh) 2012-04-04
EP2421504B1 (fr) 2017-03-08
ES2685178T5 (es) 2022-04-13
RS55862B2 (sr) 2022-12-30
SG172960A1 (en) 2011-08-29
CO6410278A2 (es) 2012-03-30
ES2685178T3 (es) 2018-10-05
EP2421504B2 (fr) 2022-08-10
LT2497461T (lt) 2018-10-10
HUE039937T2 (hu) 2019-02-28
BRPI1015447B1 (pt) 2020-01-28
TW201039862A (en) 2010-11-16
SI2421504T1 (sl) 2017-06-30
CA2755175A1 (fr) 2010-10-28
HRP20181408T4 (hr) 2022-03-04
DK2421504T4 (da) 2022-11-14
DK2497461T4 (da) 2022-02-14
RS55862B1 (sr) 2017-08-31
SI2497461T1 (sl) 2018-10-30
PL2421504T3 (pl) 2017-08-31
RS57668B2 (sr) 2022-03-31
US20120035270A1 (en) 2012-02-09
HRP20170610T4 (hr) 2022-12-09
AU2010240551A1 (en) 2011-08-04
GEP20146087B (en) 2014-05-13
EP2497461A3 (fr) 2014-01-01
EP2497461B1 (fr) 2018-06-20
ES2623936T5 (es) 2022-11-28
KR20120015305A (ko) 2012-02-21
JP2012524773A (ja) 2012-10-18
PL2497461T3 (pl) 2018-12-31
KR101713866B1 (ko) 2017-03-09
EP2497461A2 (fr) 2012-09-12
CL2011002634A1 (es) 2012-06-08
PL2421504T5 (pl) 2023-01-02
HUE034581T2 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
MA33003B1 (fr) Solutions pediatriques comprenant un betabloquant
MX2009005951A (es) Distribuidor de liquidos o unidad de purificacion de agua con alojamiento o boquilla antimicrobiana.
EP2478910A4 (fr) Agent anti-obésité, aliment ou boisson anti-obésité, agent d'amélioration de tolérance au glucose et aliment ou boisson pour l'amélioration de la tolérance au glucose
WO2008137785A3 (fr) Système de traitement de l'eau, et procédés de nettoyage en aval
WO2009155932A3 (fr) Modulation du système récepteur trpv/récepteur du domaine op vps1 pour le traitement de la douleur
WO2007096885A3 (fr) Formulations contenant un biocide non oxydant et une source d'halogene actif et son utilisation pour le traitement de l'eau
MA30132B1 (fr) Concentre emballe permettant de preparer un bouillon, une soupe, une sauce, un jus ou a utiliser comme assaisonnement, le concentre comprenant les gommes de xanthane et de guar
SI1904029T2 (sl) Oralni, hitro razpadajoäśi film, ki se ne da izpljuniti, vsebujoäś olanzapin
BR9906621A (pt) Dicarboalcóxi dioxolanos
MA30133B1 (fr) Concentre emballe permettant de preparer un bouillon, une soupe, une sauce, un jus ou a utiliser comme assaisonnement, le concentre comprenant les gommes de xanthane et de cassia
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
EP2324715A4 (fr) Boisson contenant du lait, comportant une composition de lait ayant une teneur réduite en protéine de lactosérum
BRPI0811881A8 (pt) Condimento, alimento ou bebida, composição, e método para melhorar o sabor de um sal de potássio
MA32717B1 (fr) Sels de n-[6-cis- (2.6-dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'- (trifluoromethoxy)- [1.1'-biphenyl]-3-carboxamide
UA91867C2 (ru) Применение жидкой композиции на основе гуанидинуксусной кислоты и готовый питьевой продукт, содержащий ее
ATE483720T1 (de) Verbindungen enthaltend organofluorochlorophosphatanionen
FR2928838B1 (fr) Dispositif de raccordement/protection de capteur, en particulier pour des lignes biomedicales d'hemodialyse
BR112013030904A2 (pt) Composição de peptídeos, composição de aroma, e, alimento ou bebida
FR2904756B1 (fr) Dispositif de maintien des seins pour application medicale.
FR2937421B1 (fr) Determination de la concentration en sel d'une solution aqueuse.
FR2906472B1 (fr) Solutions ioniques hypertoniques a base d'eau de mer non diluee, leur utilisation en tant que medicaments et pour la preparation de medicaments destines au traitement de la congestion nasale.
WO2009080349A3 (fr) Gestion de l'eau de nettoyage en place pour l'embouteillage et le brassage
EP1915995A4 (fr) Préparation en solution aqueuse contenant des camptothécines
Schoenstein Determination of Bromate by different IC and IC/MS methods
WO2007017259A3 (fr) Utilisation de trifluoromethylcetones specifiques pour prevenir et traiter une pancreatite